Prescription and Over-the-Counter Medications Tool Kit ... - Home
Prescription and Over-the-Counter Medications Tool Kit ... - Home
Prescription and Over-the-Counter Medications Tool Kit ... - Home
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Procedures<br />
System Name: Los Angeles County Metropolitan Transportation Authority (LACMTA)<br />
Contact: Mary Nugent<br />
(213) 922-7169<br />
nugentm@mta.net<br />
Summary: All employees must notify <strong>the</strong>ir manager, supervisor, or MTA medical<br />
personnel when <strong>the</strong>y take a Rx or OTC medication that may interfere with<br />
<strong>the</strong> safe <strong>and</strong> effective performance of <strong>the</strong>ir job duties. Safety-sensitive<br />
employees are not allowed to perform <strong>the</strong>ir duties if <strong>the</strong>ir medication<br />
carries a warning label that <strong>the</strong>ir mental functioning, motor skills, or<br />
judgment may be affected unless a physician provides a written statement<br />
that <strong>the</strong> substance will not affect <strong>the</strong> employee’s ability to perform safetysensitive<br />
duties. The Los Angeles County Metropolitan Transportation<br />
Authority (LACMTA) provides a Medical Evaluation Form for <strong>the</strong><br />
employee to provide information about each medication <strong>the</strong>y are taking.<br />
The department head or division manager checks <strong>the</strong> Medication<br />
Evaluation List to assess <strong>the</strong> appropriate action <strong>and</strong> will make one of three<br />
determinations: (1) <strong>the</strong> medication is approved to take; (2) <strong>the</strong> employee<br />
must wait at least 8 hours after taking <strong>the</strong> medication before reporting for<br />
duty; <strong>and</strong> (3) <strong>the</strong> employee is prohibited from performing safety-sensitive<br />
duties while taking this medication. If <strong>the</strong> supervisor is in doubt or has a<br />
question, he/she is to contact <strong>the</strong> MTS medical staff for guidance.<br />
LACMTA has allowed <strong>the</strong> use of a portion of its Medication Evaluation<br />
List as an example only. The draft list is currently under internal review<br />
<strong>and</strong> is not available for distribution or use. This draft list is for <strong>the</strong><br />
exclusive use of LACMTA. The Medication Evaluation List was<br />
compiled from a list of <strong>the</strong> most common medications taken by MTA<br />
employees. Restrictions were based on information obtained from <strong>the</strong><br />
Physician’s Desk Reference (PDR). <strong>Medications</strong> with warning sections<br />
that indicate <strong>the</strong> medication “may cause drowsiness, do not operate heavy<br />
machinery” were put on <strong>the</strong> restricted list. This model is an example of<br />
<strong>the</strong> third approach described in <strong>the</strong> introduction to this section.<br />
Advantages: The employee is responsible for reporting medication use. Managers <strong>and</strong><br />
supervisors have a defined list of medications that are approved <strong>and</strong> those<br />
that have restrictions. The list is based on <strong>the</strong> PDR with MRO<br />
concurrence. The form does not require supervisors to make medical<br />
judgments. It allows for quick determination by <strong>the</strong> supervisor, <strong>and</strong><br />
minimizes loss of productivity while <strong>the</strong> employee awaits a determination.<br />
Employees are not required to have forms in <strong>the</strong>ir possession prior to a<br />
physician or pharmacy visit. The process provides for cost-effective use<br />
of medical personnel.